Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Journal of Medicinal Chemistry
|
March 16, 2019
Novel 1-Methyl-1 H-pyrazole-5-carboxamide Derivatives with Potent Anthelmintic Activity
Thuy G Le, Abhijit Kundu, Atanu Ghoshal, et al.
Journal of Medicinal Chemistry
|
December 21, 2018
Structure-Activity Relationship Studies of Tolfenpyrad Reveal Subnanomolar Inhibitors of Haemonchus contortus Development
Thuy G Le, Abhijit Kundu, Atanu Ghoshal, et al.
Journal of Medicinal Chemistry
|
November 8, 2018
Optimization of Novel 1-Methyl-1 H-Pyrazole-5-carboxamides Leads to High Potency Larval Development Inhibitors of the Barber's Pole Worm
Thuy G Le, Abhijit Kundu, Atanu Ghoshal, et al.
Antimicrobial Agents and Chemotherapy
|
April 6, 2016
Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development
James S McCarthy, Louise Marquart, Silvana Sekuloski, et al.
Journal of Medicinal Chemistry
|
December 22, 2020
1-Methyl-1<i>H</i>-pyrazole-5-carboxamide Derivatives Exhibit Unexpected Acute Mammalian Toxicity
Sarah Preston, Jose Garcia-Bustos, Liam G Hall, et al.
ACS Omega
|
September 29, 2025
Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV‑2 Papain-like Protease (PL<sup>pro</sup>) Inhibitors
Victor Oliveira Gawriljuk, Gabriela Dias Noske, Rafaela Sachetto Fernandes, et al.
Science Translational Medicine
|
February 23, 2022
Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in <i>Mycobacterium abscessus</i>
Juan Manuel Belardinelli, Deepshikha Verma, Wei Li, et al.
Malaria Journal
|
May 20, 2021
A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria
Yeka Adoke, Rella Zoleko-Manego, Serge Ouoba, et al.
Science Translational Medicine
|
November 26, 2025
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with <i>Plasmodium falciparum</i>
Rebecca Webster, Damian A Oyong, Stacey Llewellyn, et al.
ACS Central Science
|
November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles
Alice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Journal of Medicinal Chemistry
|
March 16, 2019
Novel 1-Methyl-1 H-pyrazole-5-carboxamide Derivatives with Potent Anthelmintic Activity
Thuy G Le, Abhijit Kundu, Atanu Ghoshal, et al.
Journal of Medicinal Chemistry
|
December 21, 2018
Structure-Activity Relationship Studies of Tolfenpyrad Reveal Subnanomolar Inhibitors of Haemonchus contortus Development
Thuy G Le, Abhijit Kundu, Atanu Ghoshal, et al.
Journal of Medicinal Chemistry
|
November 8, 2018
Optimization of Novel 1-Methyl-1 H-Pyrazole-5-carboxamides Leads to High Potency Larval Development Inhibitors of the Barber's Pole Worm
Thuy G Le, Abhijit Kundu, Atanu Ghoshal, et al.
Antimicrobial Agents and Chemotherapy
|
April 6, 2016
Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development
James S McCarthy, Louise Marquart, Silvana Sekuloski, et al.
Journal of Medicinal Chemistry
|
December 22, 2020
1-Methyl-1<i>H</i>-pyrazole-5-carboxamide Derivatives Exhibit Unexpected Acute Mammalian Toxicity
Sarah Preston, Jose Garcia-Bustos, Liam G Hall, et al.
ACS Omega
|
September 29, 2025
Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV‑2 Papain-like Protease (PL<sup>pro</sup>) Inhibitors
Victor Oliveira Gawriljuk, Gabriela Dias Noske, Rafaela Sachetto Fernandes, et al.
Science Translational Medicine
|
February 23, 2022
Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in <i>Mycobacterium abscessus</i>
Juan Manuel Belardinelli, Deepshikha Verma, Wei Li, et al.
Malaria Journal
|
May 20, 2021
A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria
Yeka Adoke, Rella Zoleko-Manego, Serge Ouoba, et al.
Science Translational Medicine
|
November 26, 2025
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with <i>Plasmodium falciparum</i>
Rebecca Webster, Damian A Oyong, Stacey Llewellyn, et al.
ACS Central Science
|
November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles
Alice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Page
of 7